Jupiter Life Line Hospitals Ltd

Jupiter Life Line Hospitals Ltd

₹ 1,280 -2.99%
22 Jul 4:01 p.m.
About

Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.[1]

Key Points

Business Profile[1] The company has been operating for over 15 years as a corporate quaternary care healthcare service provider in the western regions of India and currently operates three hospitals under the Jupiter brand in Thane, Pune, and Indore. They operate 1194 beds, and have 1,306 doctors including specialists, physicians, and surgeons, as of March 31, 2023.

  • Market Cap 8,398 Cr.
  • Current Price 1,280
  • High / Low 1,654 / 960
  • Stock P/E 47.6
  • Book Value 178
  • Dividend Yield 0.08 %
  • ROCE 22.2 %
  • ROE 23.0 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Stock is trading at 7.18 times its book value
  • Tax rate seems low

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
201 221 228 242 243 263 273 290
151 166 183 191 190 202 211 228
Operating Profit 49 55 45 52 53 61 62 62
OPM % 25% 25% 20% 21% 22% 23% 23% 21%
2 3 2 1 4 3 8 11
Interest 10 10 11 11 12 12 1 1
Depreciation 9 10 10 10 11 11 11 10
Profit before tax 32 38 27 32 34 41 58 62
Tax % 5% 29% 101% 51% -60% 19% 25% 27%
30 27 -0 16 54 34 44 45
EPS in Rs 5.99 5.32 -0.07 2.79 9.55 5.14 6.66 6.90
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
463 486 733 893 1,070
379 419 580 691 831
Operating Profit 84 67 153 201 238
OPM % 18% 14% 21% 23% 22%
0 4 4 8 26
Interest 26 39 44 42 26
Depreciation 26 31 36 39 42
Profit before tax 33 2 77 129 195
Tax % 10% 248% 34% 43% 10%
30 -2 51 73 177
EPS in Rs 5.83 -0.45 10.05 12.90 26.94
Dividend Payout % 0% 0% 0% 0% 4%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 30%
TTM: 20%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 329%
TTM: 138%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 22%
Last Year: 23%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 51 51 51 57 66
Reserves 186 188 241 309 1,103
272 426 495 469 0
94 124 122 151 112
Total Liabilities 603 789 909 986 1,281
435 630 684 720 718
CWIP 10 26 27 29 74
Investments 2 7 3 2 17
156 126 195 235 473
Total Assets 603 789 909 986 1,281

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
74 123 137 117 115
-43 -295 -84 -104 -76
-32 184 32 18 128
Net Cash Flow -1 12 85 31 167

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 35 16 14 19 20
Inventory Days 64 48 39 44 41
Days Payable 268 217 157 164 120
Cash Conversion Cycle -169 -152 -104 -101 -59
Working Capital Days 39 -4 -9 -17 -5
ROCE % 7% 17% 21% 22%

Shareholding Pattern

Numbers in percentages

1 Recently
Sep 2023Dec 2023Mar 2024Jun 2024
40.91% 40.91% 40.91% 40.91%
4.62% 3.96% 4.17% 6.06%
12.69% 13.92% 14.16% 13.85%
41.80% 41.19% 40.76% 39.18%
No. of Shareholders 54,78239,34835,10735,797

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents